BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Turu G, Balla A, Hunyady L. The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor. Front Endocrinol (Lausanne) 2019;10:519. [PMID: 31447777 DOI: 10.3389/fendo.2019.00519] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lino CA, Barreto-chaves ML. Beta-arrestins in the context of cardiovascular diseases: Focusing on type 1 angiotensin II receptor (AT1R). Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110253] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yang Y. Functional Selectivity of Dopamine D1 Receptor Signaling: Retrospect and Prospect. Int J Mol Sci 2021;22:11914. [PMID: 34769344 DOI: 10.3390/ijms222111914] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Lymperopoulos A, Borges JI, Carbone AM, Cora N, Sizova A. Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling. Pharmacol Res 2021;174:105943. [PMID: 34662735 DOI: 10.1016/j.phrs.2021.105943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Guimarães-Nobre CC, Mendonça-Reis E, Passinho-da-Costa L, Miranda-Alves L, Clemilson Berto-Junior H. Signaling Pathway in the Osmotic Resistance Induced by Angiotensin II AT2 Receptor Activation in Human Erythrocytes. Rep Biochem Mol Biol 2021;10:314-26. [PMID: 34604421 DOI: 10.52547/rbmb.10.2.314] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Verma K, Pant M, Paliwal S, Dwivedi J, Sharma S. An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update. Front Pharmacol 2021;12:734917. [PMID: 34489714 DOI: 10.3389/fphar.2021.734917] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Turu G, Soltész-Katona E, Tóth AD, Juhász C, Cserző M, Misák Á, Balla A, Caron MG, Hunyady L. Biased Coupling to β-Arrestin of Two Common Variants of the CB2 Cannabinoid Receptor. Front Endocrinol (Lausanne) 2021;12:714561. [PMID: 34484125 DOI: 10.3389/fendo.2021.714561] [Reference Citation Analysis]
7 Eckenstaler R, Sandori J, Gekle M, Benndorf RA. Angiotensin II receptor type 1 - An update on structure, expression and pathology. Biochem Pharmacol 2021;192:114673. [PMID: 34252409 DOI: 10.1016/j.bcp.2021.114673] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 Delaitre C, Boisbrun M, Lecat S, Dupuis F. Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes. Int J Mol Sci 2021;22:6738. [PMID: 34201646 DOI: 10.3390/ijms22136738] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Rakib A, Eva TA, Sami SA, Mitra S, Nafiz IH, Das A, Tareq AM, Nainu F, Dhama K, Emran TB, Simal-Gandara J. Beta-Arrestins in the Treatment of Heart Failure Related to Hypertension: A Comprehensive Review. Pharmaceutics 2021;13:838. [PMID: 34198801 DOI: 10.3390/pharmaceutics13060838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Song X, Zou X, Ge W, Hou C, Cao Z, Zhao H, Zhang T, Jin L, Fu Y, Kong W, Yan C, Cai J, Wang J. Blocking FcγRIIB in Smooth Muscle Cells Reduces Hypertension. Circ Res 2021;129:308-25. [PMID: 33980031 DOI: 10.1161/CIRCRESAHA.120.318447] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Gomes KP, Braga PPP, de Lima CQ, Ghazale PP, Pedrino GR, Mendes EP, Pansani AP, Xavier CH, Castro CH, Colugnati DB. Antiepileptic effects of long-term intracerebroventricular infusion of angiotensin-(1-7) in an animal model of temporal lobe epilepsy. Clin Sci (Lond) 2020;134:2263-77. [PMID: 32803259 DOI: 10.1042/CS20200514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kadam PS, Mueller SC, Ji H, Liu J, Pai AV, Ma J, Speth RC, Sandberg K. Modulation of the rat angiotensin type 1a receptor by an upstream short open reading frame. Peptides 2021;140:170529. [PMID: 33744369 DOI: 10.1016/j.peptides.2021.170529] [Reference Citation Analysis]
13 Ferraino KE, Cora N, Pollard CM, Sizova A, Maning J, Lymperopoulos A. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression. Cell Signal 2021;82:109967. [PMID: 33640432 DOI: 10.1016/j.cellsig.2021.109967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
14 Das G, Das T, Chowdhury N, Chatterjee D, Bagchi A, Ghosh Z. Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19. Genomics 2021;113:1129-40. [PMID: 33189776 DOI: 10.1016/j.ygeno.2020.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
15 Rukavina Mikusic NL, Silva MG, Pineda AM, Gironacci MM. Angiotensin Receptors Heterodimerization and Trafficking: How Much Do They Influence Their Biological Function? Front Pharmacol 2020;11:1179. [PMID: 32848782 DOI: 10.3389/fphar.2020.01179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Meyer LS, Gong S, Reincke M, Williams TA. Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism. Horm Metab Res 2020;52:379-85. [PMID: 32168525 DOI: 10.1055/a-1120-8647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Audebrand A, Désaubry L, Nebigil CG. Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments. Front Cardiovasc Med 2019;6:194. [PMID: 32039239 DOI: 10.3389/fcvm.2019.00194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]